Skip to main content
All lobbying filings

THE METROHEALTH SYSTEM

Lobbying for THE METROHEALTH SYSTEM

 Filing 1st Quarter - Report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 20, 2026
Expenses
$190,000.00
What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
Ohio

Official filing document

 Government bodies contacted 4
  • Centers For Medicare and Medicaid Services (CMS)
  • Health & Human Services, Dept of (HHS)
  • HOUSE OF REPRESENTATIVES
  • SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Bills named in this filing 8
  • HR 4313
    Hospital Inpatient Services Modernization Act
  • S 2237
    Hospital Inpatient Services Modernization Act
  • HR 267
    Health Care PRICE Transparency Act
  • HR 2590
    Mental and Physical Health Care Comorbidities Act of 2025
  • S 1264
    Mental and Physical Health Care Comorbidities Act of 2025
  • HR 5256
    340B ACCESS Act
  • HR 4392
    Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025
  • HR 5371
    Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions …
 Lobbying activity 5
Medicare/Medicaid

Medicaid State Directed Payments; 340B modernization; funding for Disproportionate Share Hospitals (Medicaid DSH); funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies; impact of regional oversaturation of trauma care on patient outcomes and health system costs; H.R. 4313/S. 2237, Hospital Inpatient Services Modernization Act; H.R. 267, the Health Care Price Transparency Act; H.R. 2590/S. 1264, the Mental and Physical Health Care Comorbidities Act of 2025.

Health Issues

Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B modernization; impact of regional oversaturation of trauma care on patient outcomes and health system costs; Pandemic and All Hazards Preparedness Act reauthorization; H.R. 267, the Health care PRICE Transparency Act; H.R. 5256, the 340B ACCESS Act; H.R. 4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025.

Budget/Appropriations

Funding for drug therapeutic infusion pumps; H.R. 5371, the Continuing Appropriations and Extensions Act, 2026.

Pharmacy

H.R. 5256, the 340B ACCESS Act.

Defense

FY 2027 National Defense Authorization Act.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem